About - Porton Biopharma

About Porton Biopharma

A long history of pharmaceutical development.

We specialise in the development and manufacture of biopharmaceuticals for niche indications.

Our History

Located in the heart of Wiltshire, Porton Biopharma has a rich history in the development and manufacture of biopharmaceuticals for a wide variety of diseases.

1951 — MoD Microbiological Research Establishment opened
1979 — Ownership passed to the UK government Department of Health & Anthrax Vaccine licensed in the UK
1985 — Erwinase first licensed in the UK
2013 — The site became the centre of Public Health England
2015 — PBL spun out of PHE to run as a commercial entity, whilst still owned by the Department of Health

Anthrax Vaccine

We manufacture the UK’s licensed anthrax vaccine. It is supplied for both occupational health purposes and to protect those at risk from the use of anthrax as a biological weapon.

Erwinase (Crisantaspase)

Developed at Porton in the 1960’s, PBL remains the sole global manufacturer of Erwinase® which was first registered as a product name in the UK in 1985. Since then it has been supplied to treat haematological malignancies around the world.

Learn more

Our Facilities

Expertise in microbial fermentation is central to what we do.

A new state-of-the-art fermentation facility which has been designed and built around a 3000 litre fermenter, giving a significant increase in capacity.
Dedicated containment facilities ensure both product and operator safety.

These new facilities, together with our commitments to develop and maintain our highly trained staff, ensure that we are able to meet the latest regulatory standards and continue treating our patients

Become part of the team

If you are a motivated person who is interested in working in a high-tech environment as part of a dynamic team, then there could be a role for you.

More about us

im体育

About us